Hepatocellular adenoma causes: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
(25 intermediate revisions by 6 users not shown) | |||
Line 2: | Line 2: | ||
{{Hepatocellular adenoma}} | {{Hepatocellular adenoma}} | ||
{{CMG}}; {{AE}} {{ZAS}} | |||
==Overview== | |||
[[Estrogen]] has a central role in the development of hepatocellular adenoma. The [[Causality|causes]] of hepatocellular adenoma can include the settings where prolonged and/or excessive [[estrogen]] exposure is involved. These can include [[Oral contraceptive|oral contraceptive medications]], [[pregnancy]], long term use of [[anabolic]] [[Androgen|androgenic]] [[Steroid|steroids]], [[metabolic syndrome]], [[obesity]], [[Glycogen storage disease|glycogen storage diseases]], and [[clomiphene]]. | |||
==Causes== | |||
* [[Estrogen]] has a central role in the development of hepatocellular adenoma. | |||
* The [[Causality|causes]] of hepatocellular adenoma can include the settings involving prolonged and/or excessive [[estrogen]] exposure, such as:<ref>{{Cite journal | |||
| author = [[M. Kawakatsu]], [[V. Vilgrain]], [[S. Erlinger]] & [[H. Nahum]] | |||
| title = Disappearance of liver cell adenoma: CT and MR imaging | |||
| journal = [[Abdominal imaging]] | |||
| volume = 22 | |||
| issue = 3 | |||
| pages = 274–276 | |||
| year = 1997 | |||
| month = May-June | |||
| pmid = 9107649 | |||
}}</ref><ref>{{Cite journal | |||
| author = [[W. H. Marks]], [[N. Thompson]] & [[H. Appleman]] | |||
| title = Failure of hepatic adenomas (HCA) to regress after discontinuance of oral contraceptives. An association with focal nodular hyperplasia (FNH) and uterine leiomyoma | |||
| journal = [[Annals of surgery]] | |||
| volume = 208 | |||
| issue = 2 | |||
| pages = 190–195 | |||
| year = 1988 | |||
| month = August | |||
| pmid = 2840865 | |||
}}</ref<nowiki><ref></nowiki>{{Cite journal | |||
| author = [[H. Tesluk]] & [[J. Lawrie]] | |||
| title = Hepatocellular adenoma. Its transformation to carcinoma in a user of oral contraceptives | |||
| journal = [[Archives of pathology & laboratory medicine]] | |||
| volume = 105 | |||
| issue = 6 | |||
| pages = 296–299 | |||
| year = 1981 | |||
| month = June | |||
| pmid = 6263214 | |||
}}</ref><ref>{{Cite journal | |||
| author = [[D. Carrasco]], [[M. Barrachina]], [[M. Prieto]] & [[J. Berenguer]] | |||
| title = Clomiphene citrate and liver-cell adenoma | |||
| journal = [[The New England journal of medicine]] | |||
| volume = 310 | |||
| issue = 17 | |||
| pages = 1120–1121 | |||
| year = 1984 | |||
| month = April | |||
| doi = 10.1056/NEJM198404263101716 | |||
| pmid = 6323982 | |||
}}</ref><ref>{{Cite journal | |||
| author = [[G. B. Coombes]], [[J. Reiser]], [[F. J. Paradinas]] & [[I. Burn]] | |||
| title = An androgen-associated hepatic adenoma in a trans-sexual | |||
| journal = [[The British journal of surgery]] | |||
| volume = 65 | |||
| issue = 12 | |||
| pages = 869–870 | |||
| year = 1978 | |||
| month = December | |||
| pmid = 737424 | |||
}}</ref><ref>{{Cite journal | |||
| author = [[U. Beuers]], [[W. O. Richter]], [[M. M. Ritter]], [[B. Wiebecke]] & [[P. Schwandt]] | |||
| title = Klinefelter's syndrome and liver adenoma | |||
| journal = [[Journal of clinical gastroenterology]] | |||
| volume = 13 | |||
| issue = 2 | |||
| pages = 214–216 | |||
| year = 1991 | |||
| month = April | |||
| pmid = 1851773 | |||
}}</ref><ref>{{Cite journal | |||
| author = [[N. S. Alshak]], [[J. Cocjin]], [[L. Podesta]], [[R. van de Velde]], [[L. Makowka]], [[P. Rosenthal]] & [[S. A. Geller]] | |||
| title = Hepatocellular adenoma in glycogen storage disease type IV | |||
| journal = [[Archives of pathology & laboratory medicine]] | |||
| volume = 118 | |||
| issue = 1 | |||
| pages = 88–91 | |||
| year = 1994 | |||
| month = January | |||
| pmid = 8285839 | |||
}}</ref><ref>{{Cite journal | |||
| author = [[P. Labrune]], [[P. Trioche]], [[I. Duvaltier]], [[P. Chevalier]] & [[M. Odievre]] | |||
| title = Hepatocellular adenomas in glycogen storage disease type I and III: a series of 43 patients and review of the literature | |||
| journal = [[Journal of pediatric gastroenterology and nutrition]] | |||
| volume = 24 | |||
| issue = 3 | |||
| pages = 276–279 | |||
| year = 1997 | |||
| month = March | |||
| pmid = 9138172 | |||
}}</ref><ref>{{Cite journal | |||
| author = [[S. Bala]], [[P. H. Wunsch]] & [[W. G. Ballhausen]] | |||
| title = Childhood hepatocellular adenoma in familial adenomatous polyposis: mutations in adenomatous polyposis coli gene and p53 | |||
| journal = [[Gastroenterology]] | |||
| volume = 112 | |||
| issue = 3 | |||
| pages = 919–922 | |||
| year = 1997 | |||
| month = March | |||
| pmid = 9041254 | |||
}}</ref><ref>{{Cite journal | |||
| author = [[J. K. Baum]], [[J. J. Bookstein]], [[F. Holtz]] & [[E. W. Klein]] | |||
| title = Possible association between benign hepatomas and oral contraceptives | |||
| journal = [[Lancet (London, England)]] | |||
| volume = 2 | |||
| issue = 7835 | |||
| pages = 926–929 | |||
| year = 1973 | |||
| month = October | |||
| pmid = 4126557 | |||
}}</ref> | |||
:*[[Oral contraceptive|Oral contraceptive medications]] | |||
:*[[Pregnancy]] | |||
:*[[Glycogen storage disease type I|Glycogen storage disease types I]],[[Glycogen storage disease type II|II]] and [[Glycogen storage disease type IV|IV]] | |||
:*Long term use of [[anabolic]] [[Androgen|androgenic]] [[Steroid|steroids]] | |||
:*[[Metabolic syndrome]] | |||
:*[[Obesity]] | |||
:*[[Clomiphene]] | |||
==References== | ==References== | ||
{{reflist| | {{reflist|1}} | ||
[[Category:Disease]] | [[Category:Disease]] | ||
Line 15: | Line 132: | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Gastroenterology]] | |||
[[Category:Surgery]] | |||
[[Category:Hepatology]] |
Latest revision as of 18:24, 20 August 2019
Hepatocellular adenoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Hepatocellular adenoma causes On the Web |
American Roentgen Ray Society Images of Hepatocellular adenoma causes |
Risk calculators and risk factors for Hepatocellular adenoma causes |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Zahir Ali Shaikh, MD[2]
Overview
Estrogen has a central role in the development of hepatocellular adenoma. The causes of hepatocellular adenoma can include the settings where prolonged and/or excessive estrogen exposure is involved. These can include oral contraceptive medications, pregnancy, long term use of anabolic androgenic steroids, metabolic syndrome, obesity, glycogen storage diseases, and clomiphene.
Causes
- Estrogen has a central role in the development of hepatocellular adenoma.
- The causes of hepatocellular adenoma can include the settings involving prolonged and/or excessive estrogen exposure, such as:[1][2][3][4][5][6][7][8][9]
References
- ↑ M. Kawakatsu, V. Vilgrain, S. Erlinger & H. Nahum (1997). "Disappearance of liver cell adenoma: CT and MR imaging". Abdominal imaging. 22 (3): 274–276. PMID 9107649. Unknown parameter
|month=
ignored (help) - ↑ W. H. Marks, N. Thompson & H. Appleman (1988). "Failure of hepatic adenomas (HCA) to regress after discontinuance of oral contraceptives. An association with focal nodular hyperplasia (FNH) and uterine leiomyoma". Annals of surgery. 208 (2): 190–195. PMID 2840865. Unknown parameter
|month=
ignored (help)</ref<ref>H. Tesluk & J. Lawrie (1981). "Hepatocellular adenoma. Its transformation to carcinoma in a user of oral contraceptives". Archives of pathology & laboratory medicine. 105 (6): 296–299. PMID 6263214. Unknown parameter|month=
ignored (help) - ↑ D. Carrasco, M. Barrachina, M. Prieto & J. Berenguer (1984). "Clomiphene citrate and liver-cell adenoma". The New England journal of medicine. 310 (17): 1120–1121. doi:10.1056/NEJM198404263101716. PMID 6323982. Unknown parameter
|month=
ignored (help) - ↑ G. B. Coombes, J. Reiser, F. J. Paradinas & I. Burn (1978). "An androgen-associated hepatic adenoma in a trans-sexual". The British journal of surgery. 65 (12): 869–870. PMID 737424. Unknown parameter
|month=
ignored (help) - ↑ U. Beuers, W. O. Richter, M. M. Ritter, B. Wiebecke & P. Schwandt (1991). "Klinefelter's syndrome and liver adenoma". Journal of clinical gastroenterology. 13 (2): 214–216. PMID 1851773. Unknown parameter
|month=
ignored (help) - ↑ N. S. Alshak, J. Cocjin, L. Podesta, R. van de Velde, L. Makowka, P. Rosenthal & S. A. Geller (1994). "Hepatocellular adenoma in glycogen storage disease type IV". Archives of pathology & laboratory medicine. 118 (1): 88–91. PMID 8285839. Unknown parameter
|month=
ignored (help) - ↑ P. Labrune, P. Trioche, I. Duvaltier, P. Chevalier & M. Odievre (1997). "Hepatocellular adenomas in glycogen storage disease type I and III: a series of 43 patients and review of the literature". Journal of pediatric gastroenterology and nutrition. 24 (3): 276–279. PMID 9138172. Unknown parameter
|month=
ignored (help) - ↑ S. Bala, P. H. Wunsch & W. G. Ballhausen (1997). "Childhood hepatocellular adenoma in familial adenomatous polyposis: mutations in adenomatous polyposis coli gene and p53". Gastroenterology. 112 (3): 919–922. PMID 9041254. Unknown parameter
|month=
ignored (help) - ↑ J. K. Baum, J. J. Bookstein, F. Holtz & E. W. Klein (1973). "Possible association between benign hepatomas and oral contraceptives". Lancet (London, England). 2 (7835): 926–929. PMID 4126557. Unknown parameter
|month=
ignored (help)